+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Morocco

  • PDF Icon

    Report

  • 95 Pages
  • September 2018
  • Region: Morocco
  • GlobalData
  • ID: 4629743
Description Jump to:
CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Morocco

Summary

The Author, the industry analysis specialist, has released its latest report, "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Morocco". The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in Morocco. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure of Morocco. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and in-house analysis by the Author’s team of industry experts.

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in Morocco, and includes -
  • An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers

  • Profiles and SWOT analyses of the major players in the pharmaceutical market (Sanofi, GlaxoSmithKline, Leo Pharma, Bayer and Sothema) and major player of the medical device market (Roche Diagnostics)

  • Porter’s five forces analysis for pharmaceutical and medical devices market of Morocco

  • An insightful review of the reimbursement and regulatory landscape, of which analysis includes details of the healthcare reimbursement process, the regulatory agencies and the approval processes for new drugs and medical devices

  • Information regarding recent healthcare policies along with healthcare infrastructure and healthcare expenditure

  • An overview of the opportunities for and challenges to growth in the Moroccan healthcare market.


Reasons to buy

This report will enhance your decision-making capability by allowing you to -
  • Develop business strategies by understanding the trends shaping and driving the Moroccan healthcare market

  • Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to impact the healthcare market in the future

  • Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors

  • Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership

  • Identify, understand, and capitalize on the opportunities and challenges in the Moroccan healthcare market.

Table of Contents

Executive Summary
Overview of Pharmaceutical Market
Overview of Medical Device Market
Porter’s Five Forces Model
Market Access
Country Healthcare Landscape
Opportunities and Challenges
Appendix
List of Tables
Table 1: Pharmaceutical Market, Morocco, Pharmaceutical Sales by Therapeutic Area ($m), 2
Table 2: Salaries vs. Compensation Amounts, Morocco, 2
Table 3: Originator-Generic Price Difference, Morocco, 2
Table 4: Patent Fees, Morocco, 2
Table 5: Trademark Fees, Morocco, 2
Table 6: Trade Fairs, Morocco, 2018-2
List of Figures
Figure 1: Pharmaceutical Market, Morocco, Revenue ($bn), 2010-2
Figure 2: Medical Device Market, Morocco, Revenue ($m), 2013-2
Figure 3: Country Profile, Morocco, 2
Figure 4: Pharmaceutical Market, Morocco, Revenue ($bn), 2010-2
Figure 5: Pharmaceutical Market, Morocco, Revenue Forecast ($bn), 2018-2
Figure 6: Pharmaceutical Exports ($bn), Morocco, 2010-2
Figure 7: Top Export Partners, Morocco, 2
Figure 8: Pharmaceutical Imports ($bn), Morocco, 2010-2
Figure 9: Top Import Partners, Morocco, 2
Figure 10: Pharmaceutical Distribution Channels, Morocco, 2
Figure 11: Generics Market, Morocco, Revenue ($m), 2010-2
Figure 12: OTC Market, Morocco, Revenue ($m), 2010-2
Figure 13: Top Therapeutic Areas (Sales $m), Morocco, 2
Figure 14: Pharmaceutical Market, Morocco, Major Players
Figure 15: Medical Device Market, Morocco, Revenue ($m), 2013-2
Figure 16: Healthcare System, Morocco, 2
Figure 17: Drug Reimbursement Process, Morocco, 2
Figure 18: Distribution of Population across Health Insurance Schemes, Morocco, 2
Figure 19: RAMED Targeting System, Morocco, 2
Figure 20: Out-of-Pocket Expenditure (% of total expenditure on health), Morocco, 2009-2
Figure 21: Annual Rate of Change (%), Health Price Index, Morocco, 2010-2
Figure 22: Ministry of Health, Organization Chart, 2
Figure 23: New Drug Approval Process, Morocco, 2
Figure 24: Patent Approval Process, Morocco, 2
Figure 25: Trademark Approval Process, Morocco, 2
Figure 26: Clinical Trial Regulation, Morocco, 2
Figure 27: Pharmacy Regulations, Morocco
Figure 28: Labeling and Packaging, Morocco
Figure 29: Number of Hospitals, Morocco, 2009-2
Figure 30: Diagnostic Equipment (per million population), Morocco, 2010-2
Figure 31: Hospital Beds (per 1,000 population), Morocco, 2009-2
Figure 32: Public hospitals, Morocco, 2009-2
Figure 33: Private hospitals, Morocco, 2009-2
Figure 34: Life Expectancy (in years), Morocco, 2010-2
Figure 35: Immunization Rate (%), Morocco, 2010-2
Figure 36: PM2.5 (µg per m3), Morocco, 2010-2
Figure 37: CO2 Emissions (million tons), Morocco, 2010-2
Figure 38: Physicians (per 1,000 population), Morocco, 2010-2
Figure 39: Nurses (per 1,000 population), Morocco, 2010-2
Figure 40: Major Causes of Mortality (Number of Deaths, ‘000), Morocco, 2
Figure 41: Major Causes of Male Mortality (Number of Deaths, ‘000), Morocco, 2
Figure 42: Major Causes of Female Mortality (Number of Deaths, ‘000), Morocco, 2
Figure 43: Disability-Adjusted Life Years by Major Disease (‘000), Morocco, 2
Figure 44: Healthcare Expenditure as Percentage of GDP (%), Morocco, 2008-2
Figure 45: Public-Private Share (%), Morocco, 2008-2
Figure 46: Major Components of Healthcare Expenditure (%), Morocco, 2015

Related Topics

Related Reports

2024 Supplemental Medicare Insurance Plans Underwriting Services Global Market Size & Growth Report with Updated Recession Risk Impact - Product Image

2024 Supplemental Medicare Insurance Plans Underwriting Services Global Market Size & Growth Report with Updated Recession Risk Impact

  • Report
  • 45 Pages
  • Global
From
2024 Group Managed Care Medical Service Plans Underwriting Services Global Market Size & Growth Report with Updated Recession Risk Impact - Product Image

2024 Group Managed Care Medical Service Plans Underwriting Services Global Market Size & Growth Report with Updated Recession Risk Impact

  • Report
  • 45 Pages
  • Global
From
United States Out-of-Pocket Spending in Healthcare (Pharmaceuticals, Surgeries, Tests, Electives, Premiums, Copays, Doctor Visits, Other), 6th Edition - Product Image

United States Out-of-Pocket Spending in Healthcare (Pharmaceuticals, Surgeries, Tests, Electives, Premiums, Copays, Doctor Visits, Other), 6th Edition

  • Report
  • 214 Pages
  • United States
From
Medical Devices Reimbursement Market Size, Share & Trends Analysis Report By Payer (Public, Private), By Healthcare Setting (Hospitals, Outpatient Facilities), By Region, And Segment Forecasts, 2023 - 2030 - Product Image

Medical Devices Reimbursement Market Size, Share & Trends Analysis Report By Payer (Public, Private), By Healthcare Setting (Hospitals, Outpatient Facilities), By Region, And Segment Forecasts, 2023 - 2030

  • Report
  • 275 Pages
  • Global
From
Global Revenue Cycle Management Market Report and Forecast 2023-2031 - Product Image

Global Revenue Cycle Management Market Report and Forecast 2023-2031

  • Report
  • 147 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.